S R Keyes

18 papers receiving 599 citations

Peers

S R Keyes
Comparison fields: 5 of 79
  • Toxicology 87
  • Biochemistry 60
  • Pharmacology 60
  • Clinical Biochemistry 42
  • Molecular Biology 357
Replace Eibai Lee with:
Eibai Lee Japan
Janet Sredy United States
F. Javier Piedrafita United States
Edwin C. Chinje United Kingdom
Heather N. Tinsley United States
Timao Li Canada
Michael A. Shirley United States
C. T. Beer Canada
Sergio Porté Spain
Brice Sid Belgium
S R Keyes relative to Eibai Lee Japan Eibai Lee's profile →
Citations per field
00.5×3.2×
Eibai Lee · 1×
Citations per year

Countries citing papers authored by S R Keyes

Since Specialization
Citations

This map shows the geographic impact of S R Keyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S R Keyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S R Keyes more than expected).

Fields of papers citing papers by S R Keyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S R Keyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S R Keyes. The network helps show where S R Keyes may publish in the future.

Co-authors

The 25 scholars most cited alongside S R Keyes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S R Keyes Line = papers co-authored together S R Keyes links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 1980118
2 198290
3 197979
4 199147
5 197636
6
Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
199834
7
Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
198933
8
PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
199727
9
Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
198627
10
Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro.
198824
11 197623
12
Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells.
198723
13
Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
198918
14
Acute in vivo resistance in high-dose therapy.
199817
15 198914
16
Lisofylline as a modifier of radiation therapy.
19968
17 19915
18 19915

About S R Keyes

S R Keyes is a scholar working on Molecular Biology, Oncology, Toxicology, Cancer Research and Pharmacology, having authored 18 papers that have together received 628 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Research and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Toxicology (87 citations), Biochemistry (60 citations), Pharmacology (60 citations), Clinical Biochemistry (42 citations) and Molecular Biology (357 citations). S R Keyes has collaborated with scholars based in United States. Frequent co-authors include Dominick L. Cinti, Alan C. Sartorelli, Gary Rudnick, Sara Rockwell, Marianne Jansson, Josephine Alfano, Beverly A. Teicher, Gulshan Ara, Chris A. Pritsos and John B. Schenkman. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology, JNCI Journal of the National Cancer Institute, Cancer Chemotherapy and Pharmacology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact